LOS ANGELES--(BUSINESS WIRE)--
Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (SNCR). Investors who purchased the Company’s shares between December 6, 2016 and April 26, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the June 30, 2017 lead plaintiff motion deadline.
If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm’s website at http://www.goldberglawpc.com/, or by email at firstname.lastname@example.org.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Complaint alleges that during the Class Period, Synchronoss violated federal securities laws by making materially false and misleading public statements about its business, operations and prospects. On April 27, 2017, the Company announced during premarket hours that CEO Ronald Hovsepian and CFO John Frederick are both leaving Synchronoss “to pursue other interests.” The Company also disclosed that it “expects total revenue for the first quarter of 2017 to be $13 million to $14 million less than the company’s previously announced guidance” and “[o]perating margins are expected to be 8% to 10%, which are less than previously announced guidance.” When this news was announced to the public, the stock price of Synchronoss dropped materially, which caused investors harm.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.